PDGFRA and hepatocellular carcinoma: In contrast, the therapeutic efficacy of lenvatinib in Hepa1-6 cells ectopically overexpressing PDGFRA, was markedly diminished, thereby reaffirming the pivotal role of elevated PDGFRA levels in mediating LR in HCC cells (Fig. 4A).